Table 1.
Clinical characteristics of gastric cancer patients undergoing gastrectomy from 30 included studies.
References | Study design | Country | Period | Number of patients | Number of hospitals | Hospital volume (cases/year) | POM (death/total) (%) | Definition of POM |
---|---|---|---|---|---|---|---|---|
Wirth et al.53 | Retrospective | Switzerland | 2014–2018 | 188 | 62 | ≤10 | 1.9 | In-hospital |
>10 | 1.3 | |||||||
Narendra et al.54 | Retrospective | Australia | 2001–2015 | 796 | 49 | <5 | 5.0 | 30-day |
≥5 | 3.0 | |||||||
Iwatsuki et al.34 | Retrospective | Japan | 2011–2015 | 71 307 | 2051 | 0–11 | 3.1 | In-hospital |
12–26 | 1.7 | |||||||
27–146 | 1.2 | |||||||
Ji et al.5 | Retrospective | China | 2013–2018 | 125 683 | 515 | 1–83 | 0.44 | In-hospital |
84–238 | 0.29 | |||||||
239–579 | 0.24 | |||||||
580–1193 | 0.15 | |||||||
Diers et al.35 | Retrospective | Germany | 2009–2017 | 46 187 | 1084 | ≤10 | 6.9 | In-hospital |
11–29 | 5.8 | |||||||
≥30 | 3.9 | |||||||
Tian et al.8 | Retrospective | Australia | 2001–2015 | 1253 | 49 | <5 | 6.4 | In-hospital |
≥5 | 4.3 | |||||||
Levy et al.56 | Retrospective | Canada | 2004–2015 | 1660 | 69 | 0–2 | 6.6 | 30 days |
2.5–5 | NA | |||||||
5.5–7.5 | NA | |||||||
8–11.5 | NA | |||||||
12–22 | 3.1 | |||||||
Shibao et al.55 | Retrospective | Japan | 2012–2013 | 37 752 | 1074 | 1–35 | NA | In-hospital |
36–61 | NA | |||||||
62–97 | NA | |||||||
98–458 | NA | |||||||
Iwatsuki et al.6 | Retrospective | Japan | 2011–2015 | 145 523 | 2182 | 1–22 | 1.9 | In-hospital |
23–51 | 1.0 | |||||||
52–404 | 0.5 | |||||||
Wu et al.57 | Retrospective | China | 2000–2010 | 7905 | 185 | <10 | 4.1 | 30 days |
≥10 | 1.9 | |||||||
Claassen et al.7 | Retrospective | Netherlands | 2007–2015 | 494 | NA | 1–10 | 1.6 | In-hospital/30 days |
11–20 | 4.3 | |||||||
21–30 | 2.0 | |||||||
≥31 | 0.63 | |||||||
Haga et al.36 | Retrospective | Japan | 2000–2003 | 2045 | NA | ≤90 | 0.84 | 30 days |
>90 | 0.07 | |||||||
Ptok et al.58 | Prospective | Germany | 2007–2009 | 2897 | 140 | <5 | 7.8 | In-hospital |
5–10 | 5.5 | |||||||
11–20 | 6.6 | |||||||
>20 | 5.8 | |||||||
Busweiler et al.61 | Retrospective | Netherlands | 2007–2015 | 4837 | NA | <15 | 7.4 | 30 days |
15–39 | 6.1 | |||||||
≥40 | 4.8 | |||||||
Güller et al.60 | Prospective | Switzerland | 1999–2012 | 4404 | NA | 1–10 | 4.9 | In-hospital |
>10 | 3.3 | |||||||
Liu et al.59 | Retrospective | United States | 2010–2013 | 17 923 | 1297 | ≤4 | NA | 30 days |
>4 | NA | |||||||
Murata et al.62 | Retrospective | Japan | 2009–2011 | 5941 | 741 | <40 | 0.5 | In-hospital |
≥40 | 0.3 | |||||||
Altini et al.37 | Retrospective | Italy | 2004–2008 | 1314 | 16 | <7 | 11.9 | In-hospital/30 days |
7–21 | NA | |||||||
≥21 | 4.2 | |||||||
Smith et al.63 | Retrospective | Australia | 2000–2009 | 1621 | 84 | ≤6 | 5.1 | 30 days |
>6 | 3.8 | |||||||
Dikken et al.39 | Retrospective | Netherlands, | 2004–2009 | 9010 | NA | 1–10 | 4.4 | 30 days |
England, | 11–20 | NA | ||||||
Sweden, | ≥21 | 6.7 | ||||||
Denmark, | ||||||||
Ho et al.38 | Retrospective | Netherlands | 2008–2010 | 1024 | 88 | 1–6 | 6.1 | 30 days |
7–9 | 6.4 | |||||||
≥10 | 4.6 | |||||||
Ghaferi et al.9 | Retrospective | United States | 2005–2007 | 8838 | NA | 1–4 | 17.7 | In-hospital/30 days |
NA | NA | |||||||
NA | NA | |||||||
11–110 | 7.5 | |||||||
Kim et al.32 | Retrospective | South Korea | 2002–2005 | 11 071 | NA | <39 | 0.71 | 30 days |
39–126 | 0.86 | |||||||
>126 | 0.36 | |||||||
Skipworth et al.40 | Retrospective | Scotland | 1982–2003 | 4589 | 61 | 1–3 | 8.9 | In-hospital |
4–5 | 12.0 | |||||||
6–9 | 9.4 | |||||||
≥10 | 8.6 | |||||||
Baré et al.33 | Retrospective | Spain | 2001–2002 | 3241 | 144 | <18 | 7.9 | In-hospital |
18–35 | 11.7 | |||||||
>35 | 11.6 | |||||||
Thompson et al.41 | Prospective | Scotland | 1997–1999 | 639 | 39 | <13 | 11.9 | In-hospital/30 days |
13–19 | 9.1 | |||||||
20–34 | 10.3 | |||||||
≥35 | 10.0 | |||||||
Lin et al.42 | Retrospective | China | 2000–2003 | 11 348 | 174 | Q1 | 5.4 | In-hospital |
Q2 | 3.4 | |||||||
Q3 | 3.1 | |||||||
Q4 | 1.6 | |||||||
Q5 | 1.4 | |||||||
Wainess et al.64 | Retrospective | United States | 1988–2000 | 23,690 | NA | 1–4 | 8.3 | In-hospital |
5–8 | 7.1 | |||||||
≥9 | 6.5 | |||||||
Damhuis et al.65 | Retrospective | Netherlands | 1987–1997 | 1978 | 22 | <7 | 8.0 | 30 days |
7–10 | 9.8 | |||||||
>10 | 6.8 | |||||||
Birkmeyer et al.10 | Retrospective | United States | 1994–1999 | 31,944 | 3423 | <5 | 13.0 | In-hospital/30 days |
5–8 | 12.7 | |||||||
9–13 | 11.1 | |||||||
14–21 | 11.3 | |||||||
>21 | 8.7 |
NA, not available; OR, odds ratio; POM, postoperative mortality; Q, quintiles.